Advertisement

Topics

The SPRINT Study: Quality of Life and Cost-Effectiveness

20:00 EDT 22 Aug 2017 | NEJM

Intensive antihypertension treatment in high-risk patients was well tolerated and cost-effective.

Original Article: The SPRINT Study: Quality of Life and Cost-Effectiveness

NEXT ARTICLE

More From BioPortfolio on "The SPRINT Study: Quality of Life and Cost-Effectiveness"

Advertisement
Quick Search
Advertisement
Advertisement